Skip to main content

Table 1 Patient characteristics (n = 71)

From: CAPIRI-IMRT: a phase II study of concurrent capecitabine and irinotecan with intensity-modulated radiation therapy for the treatment of recurrent rectal cancer

Characteristics No. %
Median age (range) 53 years (30–75)  
Gender   
  Male 47 66.2
  Female 24 33.8
Extra pelvic metastases   
  No 48 67.6
  Yes 23 32.4
Recurrent sites   
  Single 48 67.6
  Multiple 23 32.4
Recurrence location (n = 101)   
  Peri-rectal region 34 33.7
  Pre-sacral region 26 25.7
  Internal iliac nodal region 23 22.8
  Perineum 8 7.9
  External iliac nodal region 6 5.9
  Inguinal nodal region 4 4.0